Charged particle therapy (CPT) offers advantages over conventional radiotherapy, such as higher local control of the tumour and the potential for less damage to healthy tissues. Despite the advantages of CPT, only a small number of controlled randomized clinical trials have compared it to conventional radiotherapy. The latest clinical data on the use of CPT, dose calculations and delivery, cost-effectiveness issues, current status, and future directions are discussed.
- Jay S. Loeffler
- Marco Durante
